| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| DBTX | Decibel Therapeutics, Inc. | President and Chief Executive Officer, Director | Sep 25, 2023 | |||
| KALV | KalVista Pharmaceuticals, Inc. | Director | Nov 23, 2024 | |||
| MGX | Metagenomi, Inc. | Director | Sep 2, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|